To promote the development of more treatments for rare diseases, sponsors should leverage data from natural history studies when it is not possible to use data from two adequate and well-controlled ...
Merck, Lundbeck and Ionis Pharmaceuticals are seeking more details from the US Food and Drug Administration’s (FDA) draft guidance on natural history studies, including discussions of using ...
In June, the federal Food and Drug Administration quietly announced a new program, the Commissioner’s National Priority Voucher, which promises the fastest approval in FDA history – just one to two ...
The Food and Drug Administration is a government agency that regulates certain food, drugs, cosmetics, and medical products.